- Home
- A-Z Publications
- Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
- Previous Issues
- Volume 23, Issue 4, 2023
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) - Volume 23, Issue 4, 2023
Volume 23, Issue 4, 2023
-
-
Targeting T Cell Metabolism as a Novel Approach for Treatment of MS: With a Focus on PFKFB3 Inhibitors
Multiple sclerosis (MS) is one of the organ-specific autoimmune diseases in which immune cells invade the neurons in the central nervous system (CNS) due to loss of tolerance to self-antigens. Consequently, inflammation and demyelination occur in the central nervous system. The pathogenesis of MS is not completely understood. However, it seems that T cells, especially Th17 cells, have an important role in diseas Read More
-
-
-
Unravelling the Influence of Nutrition and Mental Stress on Immune Response
Authors: Rashmi Mishra, Pratibha Pandey and Fahad KhanThe review article reveals the role of mental as well as biological phenomena working behind immunity. In recent times, irresistible illnesses and inflammation have been thought to be hereditary or the result of the natural working mechanism of the human body in response to the pathogenic variables working inside the human system. In the past few years, the importance of psychological adjustments, mental well-being and Read More
-
-
-
The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome
Authors: Luca Massaro, Anna Raguzzini, Paola Aiello and Débora Villaño ValenciaMetabolic syndrome, an increasing problem in western society, is a cluster of conditions that affect cardiovascular health, lipid and glucose management, increasing the risk of heart diseases, stroke and diabetes. Bioactive flavonoids are a great resource of compounds with proven antiinflammatory activities. Naringin, a natural flavanone found in citrus fruits, and its aglycone have demonstrated to ameliorate obesit Read More
-
-
-
What do we know about Toll-Like Receptors Involvement in Gout Arthritis?
Toll-like receptors (TLRs) are a well-characterized family of cell-bound pattern recognition receptors able to identify and respond to conserved structures of external microorganisms or Pathogen Molecular-Associated Pattern (PAMPs). They can also interact with Damage-Associated Molecular Patterns (DAMPs) involved with any infectious and sterile cell stress of tissue injury. Accumulated knowledge about TLRs has re Read More
-
-
-
Edible Vaccine - An Effective Way for Immunization
Authors: Divyanshi Singhal and Rashmi MishraEdible vaccines are cost-effective, easy to take, storable as well as bio-friendly. If they are administered orally, they are capable of lessening the occurrence of several diseases, like HPV, Norwalk virus, as well as Polio. They are obtained by utilizing a specific portion of the plant, which results in the formulation of an attractive encoded protein. These particular encoded proteins enhance the mucosal movement along with dimi Read More
-
-
-
Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis
Authors: Kirti Baraskar, Pratibha Thakur, Renu Shrivastava and Vinoy K. ShrivastavaThe SARS CoV-2 virus, the causative agent of COVID-19 uses the ACE-2 receptor of the host to penetrate and infect the cell, mainly in the pulmonary, renal, and cardiac tissues. The earlier reported Delta and the recent Omicron are the variants of concern. The mutations in the RBD region of spike protein are associated with increased RBD-ACE-2 receptor interaction. This binding affinity between spike protein and the Read More
-
-
-
Subversion of the Oral Microbiota and Induction of Immune-Mediated Systemic Inflammation with Special Reference to Periodontitis: Current Knowledge and Perspectives
Under steady-state circumstances, the oral microbiota is in equilibrium with host tissues, thus contributing to local and systemic health. Any interruption of such equilibrium leads to a condition of dysbiosis with the proliferation of oral pathogens able to cause gingivitis and periodontal disease. The mechanisms of periodontitis will be described, mostly emphasizing the noxious effects exerted by oral pathogens on the pe Read More
-
-
-
Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease
Non-alcoholic fatty pancreas disease (NAFPD) is a relatively new and emerging disease that is increasingly diagnosed yearly, like non-alcoholic fatty liver disease (NAFLD). It is associated especially with metabolic syndrome and obesity. As awareness of pancreatic steatosis and its clinical implications increase, it is diagnosed more frequently. The researchers have explained the clinical importance of NAFPD and the disease Read More
-
-
-
Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder
Authors: Rishabh Chaudhary, Sumeet Gupta and Samrat ChauhanBackground: Uncoupling proteins (UCPs) are unpaired electron carriers that uncouple oxygen intake by the electron transport chain from ATP production in the inner membrane of the mitochondria. The physiological activities of UCPs have been hotly contested, and the involvement of UCPs in the pathogenesis and progression of diabetes mellitus is among the greatest concerns. UCPs are hypothesised to be triggered b Read More
-
-
-
Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by damage to multiple systems and a higher risk of cardiovascular disease. In addition, several studies have found that insulin resistance (IR) is more prevalent in SLE patients than controls, increasing the risk of prediabetes, type 2 diabetes mellitus (T2DM) and morbidity. The objective of this review article was to summarize the most relevant evid Read More
-
-
-
Bisphenol A-Induced Endocrine Dysfunction and its Associated Metabolic Disorders
Authors: Meenu Maniradhan and Latchoumycandane CalivarathanBisphenol A (BPA) is an endocrine-disrupting chemical widely present in many consumer goods that poses a significant threat to our health upon exposure. Humans are exposed to BPA, which directly or indirectly causes endocrine dysfunctions that lead to metabolic disorders like obesity, fatty liver diseases, insulin resistance, polycystic ovarian syndrome, and other endocrine- related imbalances. The duration, quantity, and peri Read More
-
-
-
Effect of SGLT2 Inhibitors and Metformin on Inflammatory and Prognostic Biomarkers in Type 2 Diabetes Patients
Authors: Yang Cao, Ning Liang, Ting Liu, Jingai Fang and Xiaodong ZhangObjective: To assess the combined effect of Sodium-Glucose Transporter 2 Inhibitors (SGLT2i) and metformin treatment on inflammatory and prognostic biomarkers in patients with T2DM. Methods: Using the search terms “Sodium-Glucose Transporter 2 Inhibitors,” “Diabetes Mellitus, Type 2,” and “randomized controlled trial,” we screened the literature on PubMed, Cochrane Library, Embase, and Web of Science according Read More
-
-
-
Interleukin-6 Blockers Improve Inflammation-Induced Lipid Metabolism Impairments but Induce Liver Fibrosis in Collagen-Induced Arthritis
Background: Interleukin-6 (IL-6) receptor blockers improve systemic inflammation, however, their inconsistent effects on lipid metabolism and drug-induced liver injuries warrant further investigation. This study aimed to determine the effects of IL-6 receptor blocker therapy on lipid metabolism and liver morphology in collagen-induced arthritis. Methods: Sixty three Sprague Dawley rats were divided into control (n = Read More
-
-
-
The Relationship between Serum Iron and Thyroid Function in the Patients with Type 2 Diabetes
Authors: Congcong Wang, Song Wen, Xinlu Yuan, Mingyue Zhou, Yanyan Li, Min Gong, Jianlan Jin and Ligang ZhouPurpose: Our primary objective in this study is to determine the relationship between serum iron (Fe3+) and thyroid functions in type 2 diabetes mellitus (T2DM) patients. Materials and Methods: Glucose metabolic parameters, trace elements, such as Fe3+, and thyroid functions for 1657 type 2 diabetic patients treated at the Shanghai Pudong Hospital's Department of Endocrinology from 2018 to 2021 were assessed. Results: V Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
Most Read This Month
Article
content/journals/emiddt
Journal
10
5
false
en
